slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 11,701-11,730
Pages 3,225
Rows per page 30
Component
11,701-11,730 of 96,741
08
The slide uses a 'company favorable' assumption model to demonstrate that even under best-case scenarios, the core business is declining.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
102
The slide uses a 'villain' framing to call out specific medical professionals, linking them to questionable practices and providing visual evidence (conference flyer and video screenshot).TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
121
The slide uses a Q&A format to present expert testimony regarding alleged illegal business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
126
The slide uses a narrative structure to explain a systemic loophole, supported by a direct excerpt from an official policy document.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
128
The slide presents anecdotal evidence of systemic gaming of the organ allocation system.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
136
The slide uses highlighted quotes from transplant surgeons to build a case for potential regulatory or ethical issues regarding TransMedics' business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
148
The slide uses a Q&A format to highlight alleged unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
182
The slide uses excerpts from clinical literature to define the risks of transplanting steatotic livers.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
187
The slide uses a direct quote from a surgeon to highlight a perceived contradiction in the company's marketing claims.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
188
The slide uses a Q&A format to expose that the device is being used for high-risk, 'reckless' practices rather than standard clinical indications.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
212
The slide uses a Q&A format to substantiate claims of regulatory circumvention.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
222
The slide uses external media references (Netflix, news headlines) to establish the severity of the fraud.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
224
Uses juxtaposition of a news headline about arrests and a photo of a surgeon receiving a national award to highlight the contradiction.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
228
The slide uses a Q&A format to highlight alleged unethical practices regarding organ safety and corporate pressure.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
236
The slide uses a Q&A transcript format to support the primary allegation of unethical organ procurement practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
238
The slide uses direct quotes from former employees to support the claim of incompetence and lack of proper medical oversight.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
239
The slide uses direct quotes to build a narrative of negligence and poor surgical technique.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
263
The slide uses a Q&A format to highlight a specific allegation of corporate dishonesty.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
268
The slide presents a narrative of professional misconduct and coercion within an organ procurement organization.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
283
The slide uses direct quotes from KOLs to frame the company's technology as a commoditized, overpriced solution with no clinical advantage over traditional cold storage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
287
The slide uses highlighted text to emphasize key negative findings regarding the OCS technology's performance metrics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
312
The slide uses direct quotes from an industry expert to build a bearish case against TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
313
The slide uses a direct quote to highlight a competitive threat to TransMedics' business model.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
332
The slide presents a Q&A format to highlight a specific technical failure mode (necrosis) attributed to the device's design.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
336
The slide presents a narrative of corporate deception regarding medical device performance.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
25
The slide uses aggressive, emotive language ('dumpster fire', 'spectacle', 'circus') typical of activist short-seller reports.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Critique of Twist's management and strategy2 hits
26
Uses a 'Worldcom-esque' comparison to allege accounting fraud.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Critique of Twist's management and strategy2 hits
35
Uses news headlines to frame the CEO's integrity and the company's technological origins as questionable.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Critique of Twist's management and strategy2 hits
45
Uses a screenshot of a Wikipedia entry as primary evidence to debunk the novelty of the subject's technology.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Aha Moment2 hits
49
Uses a press release excerpt to undermine the uniqueness of the target company's IP.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Aha Moment2 hits